Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

AXTA October 28, 2025

Axalta Coating Systems Q3 2025 Earnings Call - Record margins and EPS despite sales weakness, management doubles down on buybacks

Axalta reported a strong Q3 2025 operational quarter: record adjusted EBITDA and adjusted diluted EPS even as net sales slipped amid North American macro weakness and refinish destocking. Management c...

  • Q3 net sales about $1.3 billion, down ~2% year over year, with North America the primary drag.
  • Q3 adjusted EBITDA hit a quarterly record of $294 million, with an adjusted EBITDA margin of 22.8%, marking 12 consecutive quarters of YoY adjusted EBITDA and margin growth.
  • Adjusted diluted EPS was a quarterly record $0.67, up 6% year over year, helped by lower interest expense and fewer shares outstanding.
  • +17 more takeaways
AXTA October 28, 2025

Axalta Coating Systems Q3 2025 Earnings Call - Record margins and aggressive buybacks as demand softens

Axalta reported a quarter of stronger profitability against softer top line trends, posting record adjusted EBITDA and adjusted diluted EPS while navigating mid single digit revenue declines. Manageme...

  • Net sales about $1.3 billion in Q3 2025, down 2% year over year, with North America cited as the primary soft spot.
  • Adjusted EBITDA hit a quarterly record of $294 million, yielding a company adjusted EBITDA margin of 22.8%, the twelfth consecutive quarter of year over year margin expansion.
  • Adjusted diluted EPS was $0.67, up 6% year over year, another quarterly record driven by lower interest expense and share reduction.
  • +14 more takeaways
NXPI October 28, 2025

NXP Semiconductors Q3 2025 Earnings Call - Nascent Auto and Industrial Upcycle, Restocking Still Pending

NXP beat Q3 guidance modestly, reported $3.17 billion revenue, and is guiding to $3.3 billion for Q4 as management cites strengthening order signals across automotive and industrial IoT. The company s...

  • Q3 revenue $3.17 billion, down 2% year over year, up 8% sequentially, $23 million above guidance midpoint.
  • Non-GAAP EPS $3.11, a penny above guidance; non-GAAP operating margin ~33.8%, about 170 basis points below prior year.
  • Q4 guidance: revenue $3.3 billion at midpoint, up 6% year over year and up 4% sequentially, with non-GAAP gross margin targeted at 57.5% and operating margin ~34.6% at midpoint.
  • +12 more takeaways
FTAI October 28, 2025

FTAI Aviation Ltd. Q3 2025 Earnings Call - SCI Upsized to $6B Deployment and Engine MRE Pivot Fuels Cash Flow Surge

FTAI closed Q3 by turning its strategy into scale. The company upsized its Strategic Capital Initiative to $2 billion of equity, pushing a $6 billion deployment target and a 375-aircraft portfolio by ...

  • FTAI upsized its 2025 Strategic Capital Initiative to $2.0 billion of equity, increasing expected total deployment to over $6 billion and a roughly 375-aircraft portfolio, with full deployment now targeted by mid-2026.
  • FTAI will co-invest about $380 million in the SCI, including $152 million invested year to date, holding a 19% minority equity interest versus an original 20% plan.
  • The SCI’s Maintenance Repair Exchange agreement locks in fixed-price engine exchanges for the partnership, creating a multi-year, contracted pipeline of rebuild demand for FTAI’s aerospace products business.
  • +12 more takeaways
ALKS October 28, 2025

Alkermes Third Quarter 2025 Earnings Call - Raising Guidance and Buying Avadel to Accelerate Sleep Franchise

Alkermes outperformed near-term expectations, raised full-year 2025 guidance, and announced a deal to acquire Avadel, a move that immediately expands Alkermes into sleep medicine with Lumryz and bolst...

  • Raised full-year 2025 guidance: total revenues $1.43–$1.49 billion, GAAP net income $230–$250 million, EBITDA $270–$290 million, adjusted EBITDA $365–$385 million.
  • Q3 results: total revenues $394.2 million, proprietary product net sales $317.4 million, up 16% year-over-year.
  • Announced proposed acquisition of Avadel Pharmaceuticals, expected close in Q1, which adds Lumryz (expected 2025 net revenue $265–$275 million) and an established sleep-commercial infrastructure.
  • +13 more takeaways
CARR October 28, 2025

Carrier Q3 2025 Earnings Call - Residential Destocking Forces Deep Inventory Reset Even as Commercial and Data Center Growth Accelerate

Carrier reported Q3 roughly in line with guidance, but the quarter was dominated by a sudden, severe pullback in North American residential HVAC. That destocking cost roughly $500 million of sales and...

  • Q3 results largely matched the mid-September update: reported sales $5.6bn, adjusted operating profit $823m, adjusted EPS $0.67.
  • North American residential (CSA resi) weakness equated to about a $500m sales shortfall and a 20% to 25% adjusted EPS headwind in the quarter.
  • Carrier is executing an aggressive inventory reset: field inventories down 12% YoY at end-Q3, down another ~10 percentage points since the start of the month, and management expects field inventories to be 30% lower YoY by year-end, the lowest since 2018.
  • +17 more takeaways
CURB October 28, 2025

Curbline Properties Corp. Third Quarter 2025 Earnings Call - $750M+ Acquisition Pace and Raised OFFO Guidance Back Double-Digit FFO Growth

Curbline used its first year as a stand-alone REIT to sprint, not stroll. The company raised full-year OFFO guidance, penciling in roughly $750 million of 2025 acquisitions and forecasting double-digi...

  • Raised 2025 OFFO guidance to $1.04 to $1.05 per share, driven by stronger operations and accelerated acquisition pacing.
  • Now expects ~ $750 million of 2025 investments, up from an initial $500 million target, with upside potential.
  • Q3 NOI rose 17% sequentially, attributed to rent commencement timing and acquisition volume.
  • +14 more takeaways
DORM October 28, 2025

Dorman Products Q3 2025 Earnings Call - Tariff timing boosts Q3 margins, Q4 cost hit expected

Dorman delivered a strong Q3 on the surface, with $544 million in net sales, 7.9% growth, and adjusted EPS of $2.62, up 34% year over year. The beat was largely mechanical, driven by tariff-related pr...

  • Q3 net sales were $544 million, up 7.9% year over year, driven primarily by tariff-related pricing actions.
  • Adjusted diluted EPS was $2.62, a 34% increase versus prior-year Q3, helped by margin timing and lower interest expense.
  • Adjusted gross margin expanded to 44.4% in Q3, a 390 basis point improvement, largely due to the timing mismatch between price realization and tariff-impacted COGS.
  • +12 more takeaways
VFC October 28, 2025

V.F. Corporation Q2 FY2026 Earnings Call - Sale of Dickies Accelerates Deleveraging and Sharpens Focus on Core Growth Brands

V.F. delivered a steady quarter while laying groundwork for a faster pivot to growth. Management confirmed Q2 operating income beat expectations, net debt fell sharply, and more than 65% of revenue is...

  • Company headline: Q2 revenue $2.8bn (+2% reported, -1% constant dollars), adjusted operating income $330m, above guidance ($260–$290m).
  • Dickies sale announced after receiving an inbound offer of $600m; management expects cash benefit to VF to exceed $600m after deal costs, tax, saved capex and lower interest. Proceeds will be used to pay down debt and accelerate move toward ≤2.5x leverage by FY2028.
  • Net debt (excluding lease liabilities) fell ~$1.5bn year-over-year, down ~27% ex-leases; management reiterates medium-term targets of $500–$600m operating income expansion by FY2028 and leverage ≤2.5x.
  • +11 more takeaways
EDU October 28, 2025

New Oriental Education & Technology Group Q1 FY2026 Earnings Call - Margin Expansion, K-12 Rebound and $490M Shareholder Return Plan

New Oriental reported a steady first quarter: revenue up 6.1% year over year, non-GAAP operating margin widened to 22% and management signaled a clear pivot from stabilization to shareholder returns. ...

  • Total net revenue for Q1 FY2026 up 6.1% year over year, driven by core businesses and East Buy.
  • Non-GAAP operating margin reached 22%, a 100 basis point improvement year over year, credited to operating leverage, cost control and East Buy contribution.
  • Operating income was $310.8 million, up 6% year over year; non-GAAP operating income (ex SBC and acquisition amortization) was $335.5 million, up 11.3% year over year.
  • +16 more takeaways